DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $229,920 | -5.1% | 958 | -0.3% | 0.02% | -25.0% |
| Q1 2023 | $242,210 | -87.3% | 961 | -86.6% | 0.03% | -92.3% |
| Q4 2022 | $1,905,450 | +608.3% | 7,179 | +589.6% | 0.36% | +546.4% |
| Q3 2022 | $269,000 | -6.6% | 1,041 | -8.3% | 0.06% | -49.1% |
| Q2 2022 | $288,000 | -46.5% | 1,135 | -38.1% | 0.11% | -45.5% |
| Q1 2022 | $538,000 | -3.4% | 1,833 | -11.6% | 0.20% | +124.4% |
| Q2 2021 | $557,000 | +47.0% | 2,074 | +21.6% | 0.09% | -58.1% |
| Q4 2020 | $379,000 | +82.2% | 1,705 | +25.6% | 0.22% | +277.2% |
| Q4 2019 | $208,000 | -73.3% | 1,358 | -75.1% | 0.06% | -87.5% |
| Q2 2019 | $778,000 | -9.2% | 5,443 | -37.3% | 0.46% | +256.2% |
| Q2 2018 | $857,000 | -15.1% | 8,684 | -15.7% | 0.13% | -47.1% |
| Q1 2018 | $1,009,000 | +28.0% | 10,303 | +21.4% | 0.24% | -49.1% |
| Q4 2017 | $788,000 | – | 8,488 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 232,593 | $60,115,000 | 16.52% |
| Defender Capital, LLC. | 139,231 | $35,988,000 | 14.10% |
| Third Point | 2,700,000 | $697,383,000 | 12.60% |
| Riverstone Advisors, LLC | 62,416 | $16,121,000 | 10.38% |
| Eos Focused Equity Management, L.P. | 32,304 | $8,344,000 | 9.87% |
| Alphinity Investment Management Pty Ltd | 1,185,235 | $306,134,000 | 9.81% |
| AGF Investments America Inc. | 88,205 | $22,782,000 | 8.41% |
| Front Street Capital Management, Inc. | 117,802 | $30,427,000 | 7.70% |
| CORTLAND ASSOCIATES INC/MO | 164,142 | $42,396,000 | 7.55% |
| THAMES CAPITAL MANAGEMENT LLC | 57,156 | $14,763,000 | 7.33% |